Market Research Report

Global Toxoplasmosis Treatment Market Report By Indication (Chronic Toxoplasmosis Infection, Acute Toxoplasmosis Infection), By Route Of Administration (Parenteral, Oral), By Drug Class (Pyrimethamine, Spiramycin, Leucovorin, Sulfadiazine, Folic Acid, Other), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028

ID:VMR11218221
May 2022
Report Formats: Report Formats
The global demand for Toxoplasmosis Treatment Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.

Toxoplasmosis refers to the parasitic disease that results from infection with toxoplasma gondii, an apicomplexan. It is also known as toxoplasma. It often causes flu-like symptoms that resolve without treatment, but active infection may lead to encephalitis (inflammation of the brain), blindness, and mortality. Toxoplasmosis can be avoided by wearing gloves when working outside and controlling flies and cockroaches in the house. It can be diagnosed through computed tomography scan, contrast agents, biopsy and polymerase chain reaction. Clindamycin and pyrimethamine are used as alternative treatments for toxoplasmosis.

Market Dynamics

The key factor driving the demand for the toxoplasmosis treatment market is the increasing rate of toxoplasmosis cases. An increasing number of chronic diseases that may lead to toxoplasmosis infection and the rising prevalence of foodborne illnesses are contributing to the growth of this market. Moreover, technological advancements in treatment and diagnosis, emerging markets and huge investments in research and development are further pushing the demand for this market. In addition, continuously rising government awareness programmes and continuously increasing unhygienic environments in populated countries all over the world are boosting the demand for this market. However, side effects of drugs such as pyrimethamine used in the treatment of toxoplasmosis can hamper the growth of this market.

The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of toxoplasmosis treatment. The growth and trends of toxoplasmosis treatment industry provide a holistic approach to this study. 

Market Segmentation

This section of the toxoplasmosis treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities. 

By Indication
  • Chronic Toxoplasmosis Infection
  • Acute Toxoplasmosis Infection

By Route Of Administration
  • Parenteral
  • Oral

By Drug Class
  • Pyrimethamine
  • Spiramycin
  • Leucovorin
  • Sulfadiazine
  • Folic Acid
  • Other

By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Toxoplasmosis Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

Global Toxoplasmosis Treatment Market Share by Region (Representative Graph)

Global Toxoplasmosis Treatment Market Share
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the toxoplasmosis treatment market include Vyera Pharmaceuticals LLC, Taj Accura Pharmaceuticals Ltd., Mangalam Drugs and Organics Ltd., Cerovene Healthcare PVT LTD, Greenstone LLC, Amneal Pharmaceuticals, Inc., Turing Pharmaceuticals, F. Hoffmann-La Roche AG, Teva Pharmaceutical Industries Ltd., and Baxter International Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

METHODOLOGY:

This market research report has been produced by gathering information based on primary and secondary research. Secondary research has been done using various sources, including (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications. Additionally, our team conducts extensive primary research with key industry participants to gather first-hand data. The data is then analyzed and validated by industry experts.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Frequently Asked Questions (FAQs) about this Report

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot
 
3 . TOXOPLASMOSIS TREATMENT – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 Market Attractiveness Analysis By Indication
           3.7.2 Market Attractiveness Analysis By Route Of Administration
           3.7.3 Market Attractiveness Analysis By Drug Class
           3.7.4 Market Attractiveness Analysis By Distribution Channel
           3.7.5 Market Attractiveness Analysis By Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic 
       5.5. COVID-19: Micro and Macro Factor Analysis
 
6 . GLOBAL TOXOPLASMOSIS TREATMENT MARKET ANALYSIS BY INDICATION
       6.1 Overview by Indication
       6.2 Historical and Forecast Data
       6.3 Analysis by Indication
       6.4 Chronic Toxoplasmosis Infection Historic and Forecast Sales by Regions
       6.5 Acute Toxoplasmosis Infection Historic and Forecast Sales by Regions
 
7 . GLOBAL TOXOPLASMOSIS TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
       7.1 Overview by Route Of Administration
       7.2 Historical and Forecast Data
       7.3 Analysis by Route Of Administration
       7.4 Parenteral Historic and Forecast Sales by Regions
       7.5 Oral Historic and Forecast Sales by Regions
 
8 . GLOBAL TOXOPLASMOSIS TREATMENT MARKET ANALYSIS BY DRUG CLASS
       8.1 Overview by Drug Class
       8.2 Historical and Forecast Data
       8.3 Analysis by Drug Class
       8.4 Pyrimethamine Historic and Forecast Sales by Regions
       8.5 Spiramycin Historic and Forecast Sales by Regions
       8.6 Leucovorin Historic and Forecast Sales by Regions
       8.7 Sulfadiazine Historic and Forecast Sales by Regions
       8.8 Folic Acid Historic and Forecast Sales by Regions
       8.9 Other Historic and Forecast Sales by Regions
 
9 . GLOBAL TOXOPLASMOSIS TREATMENT MARKET ANALYSIS BY DISTRIBUTION CHANNEL
       9.1 Overview by Distribution Channel
       9.2 Historical and Forecast Data
       9.3 Analysis by Distribution Channel
       9.4 Hospital Pharmacies Historic and Forecast Sales by Regions
       9.5 Retail Pharmacies Historic and Forecast Sales by Regions
       9.6 Online Pharmacies Historic and Forecast Sales by Regions
 
10 . GLOBAL TOXOPLASMOSIS TREATMENT MARKET ANALYSIS BY GEOGRAPHY
       10.1. Regional Outlook
       10.2. Introduction
       10.3. North America Sales Analysis
           10.3.1. Overview, Historic and Forecast Sales Analysis
           10.3.2. North America By Segment Sales Analysis
           10.3.3. North America By Country Sales Analysis
           10.3.4. United State Sales Analysis
           10.3.5. Canada Sales Analysis
           10.3.6. Mexico Sales Analysis
       10.4. Europe Sales Analysis
           10.4.1. Overview, Historic and Forecast Sales Analysis
           10.4.2. Europe by Segment Sales Analysis
           10.4.3. Europe by Country Sales Analysis
           10.4.4. United Kingdom Sales Analysis
           10.4.5. France Sales Analysis
           10.4.6. Germany Sales Analysis
           10.4.7. Italy Sales Analysis
           10.4.8. Russia Sales Analysis
           10.4.9. Rest Of Europe Sales Analysis
       10.5. Asia Pacific Sales Analysis
           10.5.1. Overview, Historic and Forecast Sales Analysis
           10.5.2. Asia Pacific by Segment Sales Analysis
           10.5.3. Asia Pacific by Country Sales Analysis
           10.5.4. China Sales Analysis
           10.5.5. India Sales Analysis
           10.5.6. Japan Sales Analysis
           10.5.7. South Korea Sales Analysis
           10.5.8. Australia Sales Analysis
           10.5.9. Rest Of Asia Pacific Sales Analysis
       10.6. Latin America Sales Analysis
           10.6.1. Overview, Historic and Forecast Sales Analysis
           10.6.2. Latin America by Segment Sales Analysis
           10.6.3. Latin America by Country Sales Analysis
           10.6.4. Brazil Sales Analysis
           10.6.5. Argentina Sales Analysis
           10.6.6. Peru Sales Analysis
           10.6.7. Chile Sales Analysis
           10.6.8. Rest of Latin America Sales Analysis
       10.7. Middle East & Africa Sales Analysis
           10.7.1. Overview, Historic and Forecast Sales Analysis
           10.7.2. Middle East & Africa by Segment Sales Analysis
           10.7.3. Middle East & Africa by Country Sales Analysis
           10.7.4. Saudi Arabia Sales Analysis
           10.7.5. UAE Sales Analysis
           10.7.6. Israel Sales Analysis
           10.7.7. South Africa Sales Analysis
           10.7.8. Rest Of Middle East And Africa Sales Analysis
 
11 . COMPETITIVE LANDSCAPE OF THE TOXOPLASMOSIS TREATMENT COMPANIES
       11.1. Toxoplasmosis Treatment Market Competition
       11.2. Partnership/Collaboration/Agreement
       11.3. Merger And Acquisitions
       11.4. New Product Launch
       11.5. Other Developments
 
12 . COMPANY PROFILES OF TOXOPLASMOSIS TREATMENT INDUSTRY
       12.1. Top Company Share Analysis
       12.2. Market Concentration Rate
       12.3. Vyera Pharmaceuticals LLC
           12.3.1. Company Overview
           12.3.2. Company Revenue
           12.3.3. Products
           12.3.4. Recent Developments
       12.4. Taj Accura Pharmaceuticals Ltd.
           12.4.1. Company Overview
           12.4.2. Company Revenue
           12.4.3. Products
           12.4.4. Recent Developments
       12.5. Mangalam Drugs and Organics Ltd.
           12.5.1. Company Overview
           12.5.2. Company Revenue
           12.5.3. Products
           12.5.4. Recent Developments
       12.6. Cerovene Healthcare PVT LTD
           12.6.1. Company Overview
           12.6.2. Company Revenue
           12.6.3. Products
           12.6.4. Recent Developments
       12.7. Greenstone LLC
           12.7.1. Company Overview
           12.7.2. Company Revenue
           12.7.3. Products
           12.7.4. Recent Developments
       12.8. Amneal Pharmaceuticals Inc.
           12.8.1. Company Overview
           12.8.2. Company Revenue
           12.8.3. Products
           12.8.4. Recent Developments
       12.9. Turing Pharmaceuticals
           12.9.1. Company Overview
           12.9.2. Company Revenue
           12.9.3. Products
           12.9.4. Recent Developments
       12.10. F. Hoffmann-La Roche AG
           12.10.1. Company Overview
           12.10.2. Company Revenue
           12.10.3. Products
           12.10.4. Recent Developments
       12.11. Teva Pharmaceutical Industries Ltd.
           12.11.1. Company Overview
           12.11.2. Company Revenue
           12.11.3. Products
           12.11.4. Recent Developments
       12.12. Baxter International Inc.
           12.12.1. Company Overview
           12.12.2. Company Revenue
           12.12.3. Products
           12.12.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

 

  •  Market Snapshot
  •  Drivers : Impact Analysis
  •  Restraints : Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers
  •  COVID-19 Impact Analysis by Production, Import, Export and Demand
  •  Pre V/S Post COVID-19
  •  Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  •  COVID-19: Micro and Macro Factor Analysis
  •  Analysis by Indication (USD MN)
  •  Chronic Toxoplasmosis Infection Market Sales by Geography (USD MN)
  •  Acute Toxoplasmosis Infection Market Sales by Geography (USD MN)
  •  Analysis Market by Route Of Administration (USD MN)
  •  Parenteral Market Sales by Geography (USD MN)
  •  Oral Market Sales by Geography (USD MN)
  •  Analysis by Drug Class (USD MN)
  •  Pyrimethamine Market Sales by Geography (USD MN)
  •  Spiramycin Market Sales by Geography (USD MN)
  •  Leucovorin Market Sales by Geography (USD MN)
  •  Sulfadiazine Market Sales by Geography (USD MN)
  •  Folic Acid Market Sales by Geography (USD MN)
  •  Other Market Sales by Geography (USD MN)
  •  Analysis by Distribution Channel (USD MN)
  •  Hospital Pharmacies Market Sales by Geography (USD MN)
  •  Retail Pharmacies Market Sales by Geography (USD MN)
  •  Online Pharmacies Market Sales by Geography (USD MN)
  •  Global Toxoplasmosis Treatment Market Sales by Geography (USD MN)
  •  North America Market Analysis (USD MN)
  •  United State Market Analysis (USD MN)
  •  Canada Market Analysis (USD MN)
  •  Mexico Market Analysis (USD MN)
  •  Europe Market Analysis (USD MN)
  •  Europe Market Estimate by Country (USD MN)
  •  United Kingdom Market Analysis (USD MN)
  •  France Market Analysis (USD MN)
  •  Germany Market Analysis (USD MN)
  •  Italy Market Analysis (USD MN)
  •  Russia Market Analysis (USD MN)
  •  Spain Market Analysis (USD MN)
  •  Rest of Europe Market Analysis (USD MN)
  •  Asia Pacific Market Analysis (USD MN)
  •  China Market Analysis (USD MN)
  •  Japan Market Analysis (USD MN)
  •  India Market Analysis (USD MN)
  •  South Korea Market Analysis (USD MN)
  •  Australia Market Analysis (USD MN)
  •  Rest of Asia Pacific Market Analysis (USD MN)
  •  Latin America Market Analysis (USD MN)
  •  Brazil Market Analysis (USD MN)
  •  Argentina Market Analysis (USD MN)
  •  Peru Market Analysis (USD MN)
  •  Chile Market Analysis (USD MN)
  •  Rest of Latin America Market Analysis (USD MN)
  •  Middle East & Africa Market Analysis (USD MN)
  •  Saudi Arabia Market Analysis (USD MN)
  •  UAE Market Analysis (USD MN)
  •  Israel Market Analysis (USD MN)
  •  South Africa Market Analysis (USD MN)
  •  Rest of Middle East and Africa Market Analysis (USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisition
 
 LIST OF FIGURES
 
  •  Research Scope of Toxoplasmosis Treatment Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global Toxoplasmosis Treatment Market Size, by Region (USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by Indication
  •  Market Attractiveness Analysis by Route Of Administration
  •  Market Attractiveness Analysis by Drug Class
  •  Market Attractiveness Analysis by Distribution Channel
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Market Analysis by Indication (USD MN)
  •  Chronic Toxoplasmosis Infection Market Sales by Geography (USD MN)
  •  Acute Toxoplasmosis Infection Market Sales by Geography (USD MN)
  •  Global Market Analysis by Route Of Administration (USD MN)
  •  Parenteral Market Sales by Geography (USD MN)
  •  Oral Market Sales by Geography (USD MN)
  •  Global Market Analysis by Drug Class (USD MN)
  •  Pyrimethamine Market Sales by Geography (USD MN)
  •  Spiramycin Market Sales by Geography (USD MN)
  •  Leucovorin Market Sales by Geography (USD MN)
  •  Sulfadiazine Market Sales by Geography (USD MN)
  •  Folic Acid Market Sales by Geography (USD MN)
  •  Other Market Sales by Geography (USD MN)
  •  Global Market Analysis by Distribution Channel (USD MN)
  •  Hospital Pharmacies Market Sales by Geography (USD MN)
  •  Retail Pharmacies Market Sales by Geography (USD MN)
  •  Online Pharmacies Market Sales by Geography (USD MN)
  •  Global Market by Revenue
  •  North America Market by Revenue
  •  Europe Market by Revenue
  •  Asia Pacific Market by Revenue
  •  Latin America Market by Revenue
  •  Middle East & Africa Market by Revenue
  •  Recent Development in Industry
  •  Top Company Share Analysis
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials